Stepping forward in antibody-drug conjugate development.

导出 OA

翻译打印收藏纠错

第一作者： Yiming,Jin

第一单位： Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.

作者： Yiming,Jin ^[1] ; Megan A,Schladetsch ^[1] ; Xueting,Huang ^[1] ; Marcy J,Balunas ^[1] ; Andrew J,Wiemer ^[2]

作者单位： Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA. ^[1] Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA; Institute for Systems Genomics, University of Connecticut, Storrs, CT 06269, USA. Electronic address: andrew.wiemer@uconn.edu. ^[2]

关键词 Antibody-drug conjugates (ADCs)Cancer therapy Clinical research Metabolism

主题词抗肿瘤药(Antineoplastic Agents);人类(Humans);免疫轭合物(Immunoconjugates);肿瘤(Neoplasms);美国(United States);美国食品和药物管理局(United States Food and Drug Administration)

DOI 10.1016/j.pharmthera.2021.107917

PMID 34171334

发布时间 2023-11-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交